Skip to main content
Close

A comprehensive cancer control program for BC

BC Cancer covers the entire spectrum of cancer care, from prevention and screening to diagnosis, treatment and rehabilitation.

Learn more about BC Cancer

 Content Editor ‭[4]‬

Stories​​​​

More Stories

 

 

A new combination therapy shows promise for treatment-resistant blood cancersA new combination therapy shows promise for treatment-resistant blood cancersA BC Cancer research group led by Dr. Xiaoyan Jiang has recently uncovered a new therapeutic target for drug-resistant blood cancers, in blood cancer stem cells from chronic myeloid leukemia (CML) patients.http://www.bccancer.bc.ca/about/news-stories/stories/a-new-combination-therapy-shows-promise-for-treatment-resistant-blood-cancers2018-04-06T07:00:00Z
BC Cancer - Kelowna celebrates 20 yearsBC Cancer - Kelowna celebrates 20 yearsOn April 3, 1998, BC Cancer’s fourth treatment centre opened in Kelowna. http://www.bccancer.bc.ca/about/news-stories/stories/bc-cancer-kelowna-celebrates-20-years2018-04-03T07:00:00Z
Dr. Joseph Connors retires from clinical practice after 37 years at BC CancerDr. Joseph Connors retires from clinical practice after 37 years at BC CancerAn award-winning lymphoid cancer clinician scientist, best known for his research and treatment of Hodgkin and non-Hodgkin lymphoma, chronic lymphocytic leukemia and multiple myeloma.http://www.bccancer.bc.ca/about/news-stories/stories/dr-joseph-connors-retires-from-clinical-practice-after-37-years-at-bc-cancer2018-03-29T07:00:00Z
Moving on up – new exercise resources for cancer patientsMoving on up – new exercise resources for cancer patientsFor patients with cancer – from those recently diagnosed to post-treatment – regular exercise is recommended.http://www.bccancer.bc.ca/about/news-stories/stories/moving-on-up-–-new-exercise-resources-for-cancer-patients2018-03-14T07:00:00Z
BC Cancer’s Dr. David Huntsman named 2018 Aubrey J. Tingle Prize recipientBC Cancer’s Dr. David Huntsman named 2018 Aubrey J. Tingle Prize recipientThis award is given by the Michael Smith Foundation for Health Research (MSFHR) to a British Columbia clinician scientist whose research has had a significant impact on advancing research, improving health and the health care system.http://www.bccancer.bc.ca/about/news-stories/stories/bc-cancer’s-dr-david-huntsman-named-2018-aubrey-j-tingle-prize-recipient2018-03-01T08:00:00Z

 Content Search ‭[1]‬

 

 

Early colon cancer screening test sensitivityEarly colon cancer screening test sensitivityhttp://www.bccancer.bc.ca/about/news-stories/news/2018/early-colon-cancer-screening-test-sensitivity2018-04-19T07:00:00Z
Canadian pancreatic cancer research team provides personalized medicine, new hope to patientsCanadian pancreatic cancer research team provides personalized medicine, new hope to patientsVANCOUVER – Canadian pancreatic cancer researchers are joining forces under a Terry Fox initiative bringing new hope for patients with this deadly disease. http://www.bccancer.bc.ca/about/news-stories/news/2018/canadian-pancreatic-cancer-research-team-provides-personalized-medicine-new-hope-to-patients2018-03-07T08:00:00Z
Marking World Cancer Day with New Indigenous Cervical Screening MaterialsMarking World Cancer Day with New Indigenous Cervical Screening Materialshttp://www.bccancer.bc.ca/about/news-stories/news/2018/marking-world-cancer-day-with-new-indigenous-cervical-screening-materials2018-02-05T08:00:00Z
BC Cancer team wins prestigious $11.9-million in project funding to develop novel tests for lymphoma patients who relapseBC Cancer team wins prestigious $11.9-million in project funding to develop novel tests for lymphoma patients who relapseVANCOUVER – Today, a research team at BC Cancer will receive $11.9-million in funding for an innovative precision health project that has the potential to significantly change outcomes for patients facing a relapse of lymphoid cancer.http://www.bccancer.bc.ca/about/news-stories/news/2018/bc-cancer-team-wins-prestigious-$11-9-million-in-project-funding-to-develop-novel-tests-for-lymphoma-patients-who-relapse2018-01-23T08:00:00Z
Early colon cancer screening test for average-risk patients resumesEarly colon cancer screening test for average-risk patients resumesVancouver — Fecal immunochemical testing, or FIT, part of the early screening process for colon cancer, resumes following a temporary suspension.http://www.bccancer.bc.ca/about/news-stories/news/2017/early-colon-cancer-screening-test-for-average-risk-patients-resumes2017-12-14T08:00:00Z

SOURCE: A comprehensive cancer control program for BC ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer. All Rights Reserved.

    Copyright © 2018 Provincial Health Services Authority